Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
- Resource Type
- Source
- European Respiratory Journal
European Respiratory Journal, 2022, 59 (4), pp.2200166. ⟨10.1183/13993003.00166-2022⟩
The European respiratory journal, vol 59, iss 4
European Respiratory Journal, 59, 4
Digital.CSIC. Repositorio Institucional del CSIC
instname
The European respiratory journal
European Respiratory Journal, 59 - Subject
[SDV]Life Sciences [q-bio] Respiratory System Drug Resistance Antitubercular Agents Infektionsmedicin Medical and Health Sciences Drug Resistance, Multiple, Bacterial Tuberculosis, Multidrug-Resistant 11 Medical and Health Sciences Human Biology & Physiology MESH: Microbial Sensitivity Tests 10179 Institute of Medical Microbiology Bacterial Multidrug-Resistant Infectious Diseases 5.1 Pharmaceuticals Development of treatments and therapeutic interventions Infection Life Sciences & Biomedicine Multiple Model organisms Pulmonary and Respiratory Medicine Infectious Medicine Immunology Infectious Disease 610 Medicine & health Microbial Sensitivity Tests Vaccine Related Rare Diseases Clinical Research Biodefense MESH: Drug Resistance, Bacterial Drug Resistance, Bacterial Tuberculosis Humans Science & Technology MESH: Humans Antimycobacterial Susceptibility Testing Group FOS: Clinical medicine Prevention MESH: Drug Resistance, Multiple, Bacterial Mycobacterium tuberculosis Eucast MESH: Antitubercular Agents lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] Orphan Drug Emerging Infectious Diseases Good Health and Well Being 2740 Pulmonary and Respiratory Medicine 570 Life sciences biology Human medicine Antimicrobial Resistance Model - Language
- ISSN
- 0903-1936
1399-3003